Neurodegenerative diseases (NDs) are often age-related disorders that can cause dementia
in people, usually over 65 years old, are still lacking effective therapies. Some NDs have …

Elderly people are the assets of the country and the government can ensure their peaceful
and healthier life. Life expectancy of individuals has expanded with technological …

Background To examine the association between regular use of proton pump inhibitors and
the risk of incident dementia, including dementia subtypes, and whether the association …

Abstract Introduction Benzodiazepines (BZDs) are commonly prescribed for anxiety and
agitations, which are early symptoms of Alzheimer's disease and related dementias (ADRD) …

Early pharmacoepidemiological studies suggested that Proton Pump Inhibitors (PPIs) might
increase the risk of Alzheimer's Disease (AD) and non-AD related dementias. These findings …

Alzheimer's disease (AD) is a neurodegenerative disorder that can cause a significant
impairment in physical and cognitive functions. Gait disturbances are also reported as a …

Background Recent findings suggest a link between gout and the development of dementia.
Early treatment with colchicine is recommended as a first‐line therapy for gout flares. Animal …

Introduction Alzheimer's disease (AD) is a progressive neurodegenerative disease that
currently affects 6.2 million people in the United States and is projected to impact 152 million …

Background: Growing evidence links air pollution exposure to the risk of dementia. We
hypothesized that hypertension may partially mediate this effect. Methods: We previously …

The wave of individuals impacted by dementia continues to rise rapidly as worldwide
lifespan increases. Dietary strategies to slow cognitive decline and prolong time to clinical …